www.OSIR.org.in

Nov 4 (Reuters) - Genzyme Corp (GENZ.O: Quote , Profile , Research , Stock Buzz ) said it would co-develop and market two adult stem cell products of Osiris Therapeutics (OSIR.O: Quote , Profile , Research , Stock Buzz ) that are being tested for
Source: www.reuters.com

Amylin, Orient-Express, PFG, Sun: U.S. Equity Movers (Correct) - Bloomberg
Nov. 4 (Bloomberg) — The following companies are having unusual price changes in U.S. trading today. Stock symbols are in parentheses, and share prices are as of 12:15 p.m. in New York. Amylin Pharmaceuticals Inc. (AMLN US) retreated 21 percent to
Source: www.bloomberg.com

UPDATE 1-Celgene stem cell therapy gets FDA nod for human trials - Reuters
Nov 10 (Reuters) - Biotechnology giant Celgene Corp (CELG.O: Quote , Profile , Research , Stock Buzz ) said it received approval from U.S. health regulators to start human testing of its experimental stem-cell therapy for the treatment of Crohn’s
Source: www.reuters.com

This entry was posted on Sunday, November 30th, 2008 at 4:15 am and is filed under OSIR. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.